Tonetti Daniel A, Desai Shashvat M, Casillo Stephanie, Stone Jeremy, Brown Merritt, Jankowitz Brian, Jovin Tudor G, Gross Bradley A, Jadhav Ashutosh
Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
UPMC Stroke Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
J Neurointerv Surg. 2020 Jun;12(6):548-551. doi: 10.1136/neurintsurg-2019-015330. Epub 2019 Nov 1.
For patients undergoing mechanical thrombectomy, numerous (>3) thrombectomy passes may be harmful. However, non-recanalization leads to poor outcomes. For patients requiring multiple thrombectomy passes to achieve reperfusion, it remains unclear if the risk/benefit ratio favors recanalization.
To test the hypothesis that the benefits afforded by successful reperfusion outweigh the risk conveyed by the numerous passes required.
We retrospectively reviewed prospectively collected data for patients presenting to a comprehensive stroke center with anterior circulation large vessel occlusion (ACLVO) and undergoing thrombectomy requiring more than one pass over 24 months. We stratified patients into three groups: group 1 (successful reperfusion in 2-3 passes), group 2 (successful reperfusion in ≥4 passes), and group 3 (unsuccessful reperfusion).
250 patients with ACLVO constituted the study cohort. Despite similar demographics, group 2 patients had better clinical outcomes than those in group 3 at 24 hours (National Institutes of Health Stroke Scale (NIHSS) score 13.5 vs 19.1, p<0.001) and at 90 days (modified Rankin Scale score 0-2 rates of 31.1% vs 0.0%, p=0.006) On multivariate logistic regression analysis, age (p=0.034), Alberta Stroke Program Early CT Score (p<0.01), NIHSS score (p=0.02), and parenchymal hematoma type 2 (p=0.015) were significant predictors of functional independence among those who achieved successful reperfusion, but the number of passes required did not predict outcome for these patients (p=0.74).
Patients who achieve successful reperfusion after many passes have better clinical outcomes than those who do not, despite the number of passes and procedural time required. The number of passes required to achieve successful reperfusion beyond the first pass is not a predictor of functional independence.
对于接受机械取栓术的患者,多次(>3次)取栓可能有害。然而,未再通会导致预后不良。对于需要多次取栓才能实现再灌注的患者,风险/获益比是否有利于再通仍不清楚。
检验成功再灌注带来的益处超过所需多次取栓带来的风险这一假设。
我们回顾性分析了前瞻性收集的24个月内就诊于一家综合卒中中心、患有前循环大血管闭塞(ACLVO)且接受取栓术需要不止一次取栓的患者数据。我们将患者分为三组:第1组(2 - 3次取栓成功再灌注)、第2组(≥4次取栓成功再灌注)和第3组(再灌注失败)。
250例ACLVO患者构成研究队列。尽管人口统计学特征相似,但第2组患者在24小时时(美国国立卫生研究院卒中量表(NIHSS)评分13.5 vs 19.1,p<0.001)和90天时(改良Rankin量表评分0 - 2级比例分别为31.1% vs 0.0%,p = 0.006)的临床结局优于第3组。多因素逻辑回归分析显示,年龄(p = 0.034)、阿尔伯塔卒中项目早期CT评分(p<0.01)、NIHSS评分(p = 0.02)和2型实质内血肿(p = 0.015)是成功再灌注患者功能独立的显著预测因素,但所需取栓次数并不能预测这些患者的结局(p = 0.74)。
尽管需要多次取栓且手术时间较长,但多次取栓后成功再灌注的患者比未成功再灌注的患者临床结局更好。首次取栓后实现成功再灌注所需的取栓次数并非功能独立的预测因素。